ALK21-004: Single-dose Opiate Challenge of Medisorb® Naltrexone (VIVITROL®) in Adults Who Use Opioids

NCT01218984 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

27

Enrollment

INDUSTRY

Sponsor class

Conditions

Opiate Dependence

Interventions

DRUG: Medisorb naltrexone 75 mg
DRUG: Medisorb naltrexone 150 mg
DRUG: Medisorb naltrexone 300 mg
DRUG: Hydromorphone (10 mg/mL)
DRUG: Naloxone Challenge and Oral Naltrexone Tolerability Testing

Sponsor

Alkermes, Inc.